- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1909EUR$2,000USD£1,599GBP
- Report
- October 2024
- 197 Pages
Global
From €3383EUR$3,545USD£2,835GBP
€3759EUR$3,939USD£3,150GBP
- Report
- May 2024
- 132 Pages
Global
From €6203EUR$6,499USD£5,197GBP
- Report
- June 2024
- 200 Pages
Global
From €7587EUR$7,950USD£6,357GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1193EUR$1,250USD£1,000GBP
- Report
- January 2022
- 60 Pages
Global
From €3770EUR$3,950USD£3,159GBP
- Report
- November 2023
- 83 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- May 2023
- 79 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- October 2023
- 78 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- May 2023
- 80 Pages
Global
From €3500EUR$3,929USD£3,035GBP
- Report
- April 2022
- 48 Pages
Global
From €1909EUR$2,000USD£1,599GBP
- Drug Pipelines
- August 2020
- 35 Pages
Global
From €1909EUR$2,000USD£1,599GBP

The Pollen Allergy Drugs market is a subset of the Allergy Drugs market, which is composed of medications used to treat allergic reactions. These drugs are used to reduce the symptoms of allergic rhinitis, which is caused by an allergic reaction to pollen. Common symptoms of allergic rhinitis include sneezing, runny nose, itchy eyes, and nasal congestion. Pollen Allergy Drugs are typically administered orally or through nasal sprays, and can be either over-the-counter or prescription medications.
Common Pollen Allergy Drugs include antihistamines, decongestants, corticosteroids, and leukotriene modifiers. These drugs work by blocking the release of histamine, a chemical released by the body during an allergic reaction. Antihistamines are the most commonly used Pollen Allergy Drugs, and are available in both over-the-counter and prescription forms.
Some companies in the Pollen Allergy Drugs market include GlaxoSmithKline, Merck & Co., Sanofi, Pfizer, and Novartis. Show Less Read more